Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 314.80
Change Today -5.20 / -1.62%
Volume 6.7K
BIOV On Other Exchanges
Tel Aviv
As of 9:24 AM 04/26/15 All times are local (Market data is delayed by at least 15 minutes).

bio view ltd (BIOV) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/14/14 - $388.00
52 Week Low
12/25/14 - $278.70
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIO VIEW LTD (BIOV)

Related News

No related news articles were found.

bio view ltd (BIOV) Related Businessweek News

No Related Businessweek News Found

bio view ltd (BIOV) Details

BioView Ltd. develops, manufactures, assembles, markets, and services automated cell diagnostic systems for use in cytology, cytogenetics, hematology, and pathology laboratories. It offers imaging and offline analysis workstations, and preparation kits to medical institutions, commercial laboratories, and universities. The company’s products comprise DUET-3 and ALLEGRO PLUS scanning stations for scanning and sorting hematopoietic cells, amniocytes, cells from voided urine samples, sperm cells, metaphases, and tissues; ACCORD scanning station for analyzing breast and other tissues samples, hematopoietic cells, amniocytes, and voided urine samples; and LEGATO imaging and analysis system, a microscope expansion kit for the analysis of cell suspension and tissue based samples hybridized with fluorescent probe sets. It also provides Solo offline analysis workstation for offline analysis of cases; SoloWeb, a Web based review, analysis, and reporting software that enables streamlining of the laboratory reporting steps for tissue and cell suspension samples; and BioView reagent kits for the preparation of peripheral blood, bone marrow, and uncultured amniocytes samples for scanning. BioView Ltd. offers its products in Israel, North America, and Europe. BioView Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.

Founded in 2000

bio view ltd (BIOV) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: 758.0K
Co-Founder and Executive Vice President
Total Annual Compensation: 598.0K
Vice President of Finance
Total Annual Compensation: 358.0K
Chief Executive Officer of BioView Inc - USA ...
Total Annual Compensation: 597.0K
Compensation as of Fiscal Year 2013.

bio view ltd (BIOV) Key Developments

Bio View Ltd., Annual General Meeting, Nov 04, 2014

Bio View Ltd., Annual General Meeting, Nov 04, 2014., at 11:00 Israel Standard Time.

Bio View Ltd. Reports Earnings Results for the First Half of 2014

Bio View Ltd. reported earnings results for the first half of 2014. For the first half, the company reported revenue of ILS 14.8 million, up 36%, compared with the first half of 2013. The company posted profit of ILS 828,000 compared with a loss of ILS 1.4 million last year.

BioView Ltd. Expands its Connections with Abbot Laboratories

BioView Ltd. is expanding its connections with Abbot Laboratories. BioView notified the TASE that it had signed a cooperation agreement with Abbot for development purposes. Under the current agreement, Abbot is slated to develop signs using Fish technology, which can identify an excess or lack of certain genes in a cell, and detect whether a certain gene is playing a role in the development of diseases, for research and testing purposes. BioView will develop imaging software for these markers. Each side will bear its own costs - Abbot for developing the sign, and BioView for developing the software. BioView said in its announcement that the products resulting from this joint development would be marketed and distributed by Abbot under the distribution agreement between the two companies. Under the distribution agreement signed in June 2013, Abbot is the global distributor for the Duet systems being developed by BioView. These systems perform automatic scanning, diagnosis, and control of biological samples. The agreement gives Abbot exclusive worldwide distribution rights to BioView's products, excluding the US and Canada, where exclusivity is not granted. Marketing by Abbot in the US and Canada takes place simultaneously with direct distribution by BioView and its partners.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOV:IT 314.80 -5.20

BIOV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIOV.
View Industry Companies

Industry Analysis


Industry Average

Valuation BIOV Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO VIEW LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at